Revive Therapeutics Ltd (OTCPK:RVVTF) Stock News, Headlines & Updates
Revive Therapeutics Ltd Stock News from GuruFocus
- 1
Jul 02, 2024
Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure
Marketwired • 1:00pm
Jun 12, 2024
Revive Therapeutics Provides Update on FDA Type C Meeting for Clinical Study of Bucillamine to Treat Long COVID
Marketwired • 9:00am
Jun 10, 2024
Revive Therapeutics Provides Update From FDA Meeting for Long COVID Diagnostic Product
Marketwired • 7:00am
Apr 23, 2024
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID
Marketwired • 6:00am
Apr 18, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news